These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16425355)

  • 1. Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression.
    Zekri AR; Ashour MS; Hassan A; Alam El-Din HM; El-Shehaby AM; Abu-Shady MA
    World J Gastroenterol; 2005 Nov; 11(42):6624-30. PubMed ID: 16425355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.
    Yue M; Deng X; Zhai X; Xu K; Kong J; Zhang J; Zhou Z; Yu X; Xu X; Liu Y; Zhu D; Zhang Y
    Immunol Lett; 2013 May; 152(2):89-95. PubMed ID: 23680070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions.
    Zekri AN; El Deeb S; Bahnassy AA; Badr AM; Abdellateif MS; Esmat G; Salama H; Mohanad M; El-Dien AE; Rabah S; Abd Elkader A
    World J Gastroenterol; 2018 Mar; 24(11):1228-1238. PubMed ID: 29568203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Th1/Th2 imbalance in HCV-related liver cirrhosis].
    Sakaguchi E; Kayano K; Segawa M; Aoyagi M; Sakaida I; Okita K
    Nihon Rinsho; 2001 Jul; 59(7):1259-63. PubMed ID: 11494534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-18 and interferon-gamma in HCV-related hepatocellular carcinoma: a model of interplay between immune status and cancer.
    Perrella O; Cuomo O; Sbreglia C; Monaco A; Gnarini MR; Gentile B; Perrella M; Perrella A
    J Biol Regul Homeost Agents; 2009; 23(4):251-8. PubMed ID: 20003764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study.
    Huang YS; Hwang SJ; Chan CY; Wu JC; Chao Y; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):327-33. PubMed ID: 10389289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10 and IL-12p40 in Egyptian patients with HCV-related chronic liver disease.
    Hassoba H; Leheta O; Sayed A; Fahmy H; Fathy A; Abbas F; Attia F; Serwah A
    Egypt J Immunol; 2003; 10(1):1-8. PubMed ID: 15719617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine profiles and hepatic injury in occult hepatitis C versus chronic hepatitis C virus infection.
    Mousa N; Eldars W; Eldegla H; Fouda O; Gad Y; Abousamra N; Elmasry E; Arafa M
    Int J Immunopathol Pharmacol; 2014; 27(1):87-96. PubMed ID: 24674682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC.
    Baraka K; Abozahra RR; Badr E; Abdelhamid SM
    BMC Cancer; 2023 Oct; 23(1):938. PubMed ID: 37798688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease.
    Kakumu S; Okumura A; Ishikawa T; Yano M; Enomoto A; Nishimura H; Yoshioka K; Yoshika Y
    Clin Exp Immunol; 1997 Sep; 109(3):458-63. PubMed ID: 9328122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
    PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection.
    Fan XG; Liu WE; Li CZ; Wang ZC; Luo LX; Tan DM; Hu GL; Zhang Z
    Mediators Inflamm; 1998; 7(4):295-7. PubMed ID: 9792341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
    Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
    Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
    Motawi TK; Shaker OG; Ismail MF; Sayed NH
    Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-α and IL-10 polymorphisms increase the risk to hepatocellular carcinoma in HCV infected individuals.
    Aroucha DC; Carmo RF; Vasconcelos LR; Lima RE; Mendonça TF; Arnez LE; Cavalcanti Mdo S; Muniz MT; Aroucha ML; Siqueira ER; Pereira LB; Moura P; Pereira LM; Coêlho MR
    J Med Virol; 2016 Sep; 88(9):1587-95. PubMed ID: 26890368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of SEN virus on immunoblot INNO-LIA HCV reactivity pattern and disease outcome in Egyptian hepatocellular carcinoma patients.
    Alam El-Din HM; Abo-Shadi MA; Helal A
    Egypt J Immunol; 2007; 14(1):1-10. PubMed ID: 18689276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma associates with Th1/Th2 imbalance that coincides with disease progression and immunotherapy response.
    Lauerova L; Dusek L; Simickova M; Kocák I; Vagundová M; Zaloudík J; Kovarík J
    Neoplasma; 2002; 49(3):159-66. PubMed ID: 12098001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma.
    Kim MJ; Jang JW; Oh BS; Kwon JH; Chung KW; Jung HS; Jekarl DW; Lee S
    Cytokine; 2013 Nov; 64(2):516-22. PubMed ID: 24035756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.